Rahmi A. Gafur, Susi Aulina, Audry Devisanty Wuysang, Irfan Idris, Ashari Bahar, Nurussyariah Hammado, Muhammad Yunus Amran
Pain is a health problem phenomenon that most often brings patients to see a doctor. Pain intensity is the most often domain which assessed in clinical and research settings. Loeser suggests that four elements (nociception, pain, suffering, pain behaviour) need to be considered when evaluating patients with pain. Based on the biopsychosocial approach and the concept of pain from Loeser, a pain assessment was made and called "Alternative Method of Quantitative Pain Assessment (MAPKN)". The purpose of this study was to determine the validity of MAPKN in assessing the intensity of nociceptive, mixed, and neuropathic pain. This cross-sectional study was conducted at Wahidin Sudirohusodo Hospital, Makassar in January-May 2023. Demographic data, assessment of types of pain complaints by pain detect and pain intensity by NRS and MAPKN were collected. Subjects were grouped into nociceptive, mixed, and neuropathic pain groups. This study was conducted on 415 pain patients consisting of 163 nociceptive pain, 119 mixed pain, and 133 neuropathic pain. In the nociceptive pain group, MAPKN showed sensitivity 92.59%, specificity 96.43%, AUC 0,959 and a p value <0.001. In the mixed pain group, MAPKN showed sensitivity 98.17%, specificity 80.00%, AUC 0,836 and a p-value of 0.001. In the neuropathic pain group, MAPKN showed sensitivity 92.06%, specificity of 85.71%, AUC 0,951 and a p<0.001. The AUC value of 0.959 (96%) indicates that the diagnostic value of the MAPKN score in assessing pain intensity in the nociceptive pain group is excellent (>90%-100%). AUC value of 0.836 (83%) indicates that the diagnostic value of the MAPKN score in assessing pain intensity in the mixed pain group is good (> 80%-90%). The AUC value of 0.951 (95%) indicates that the diagnostic value of the MAPKN score in assessing pain intensity in the neuropathic pain group is excellent (>90%-100%). This is in accordance with research conducted by Eka Pranata 2004 that MAPKN has strong discriminant validity in assessing pain intensity. MAPKN is valid and has excellent diagnostic value in assessing nociceptive and neuropathic pain intensity, MAPKN is valid and has good diagnostic value in assessing mixed pain intensity. © 2023, PT Mattawang Mediatama Solution. All rights reserved.
Department of Neurology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia; Department of Physiology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia; Sport and Health Science Faculty, Universitas Negeri Makassar, Indonesia
